| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42.2M | -6.0% | -9.4% |
| Cost of Revenue | $2.1M | -7.1% | -2.9% |
| R&D Expense | $6.4M | -14.8% | -32.4% |
| SG&A Expense | $17.8M | -13.8% | +8.2% |
| Operating Income | $2.0M | -0.5% | -62.4% |
| Pre-tax Income | $3.7M | +69.2% | -31.6% |
| Income Tax | $13K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $10.7M | -7.7% | +35.4% |
| Current Assets | $81.6M | +5.4% | +37.4% |
| Total Assets | $192.9M | +2.6% | +11.1% |
| Current Liabilities | $32.1M | -0.3% | +15.5% |
| Total Liabilities | $57.6M | -4.2% | -1.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $23.1M | — | — |
| Investing Cash Flow | -$9.4M | — | — |
| Financing Cash Flow | -$3.2M | — | — |
| -38.1% |
| Net Income | $2.5M | +72.4% | -26.2% |
| $56.9M |
| +7.9% |
| +92.6% |